Mobilization with movement, thoracic spine manipulation, and dry needling for the management of temporomandibular disorder:

Steigerwald/Maher TMD disability questionnaire was completed at the 2-month follow-up. Repeated measure ANOVAs were employed to determine the effects of the intervention on each outcome. Within-group effect sizes were calculated in order to assess clinical effectiveness. The ANOVA revealed significant decreases (all, p  <  0.01) VAS mean, VAS Worst, and VAS Best between baseline and final visit of 25.7 (95% CI; 17.7, 33.8); 33.2 (95% CI; 23.4, 43.0); 18.4 (12.1, 24.7); and 28.3 (95% CI; 18.8, 37.9); 36.1 (95% CI; 25.0, 47.3); 19.7 (95% CI; 12.8, 26.7) between baseline and the 2-month follow-up periods, respectively. Additionally, the ANOVA showed significant increases (all, p  <  0.01) in MMO and disability following the physical therapy management strategy between baseline and final visit with a mean of 11.4 (95% CI, 6.9, 15.9) and 10.2 (95% CI, 5.2, 15.2) between baseline and the 2-month follow-up. Within-group effect sizes were large (d  >  1.0) for all outcomes at both follow-up periods.

Individuals with TMD treated with a multimodal treatment exhibited significant and clinical improvements in pain intensity, disability, and MMO.

Cervical Arterial Dysfunction

Join Dr Roger Kerry to learn how to make safe clinical decisions taking into account the risks associated with Cervical Arterial Dysfunction (CAD) based on the latest evidence and framework.